Tag: design

1-for-60 reverse stock split to become effective as of the opening of trading on June 16, 2025

Large-scale testing by Fluence and CSA Group shows Gridstack Pro 5000 system, delivering up to 5.6 MWh in a 20-foot enclosure, surpassing current and emerging safety standards 

MONTREAL, June 12, 2025 (GLOBE NEWSWIRE) -- Stingray (TSX: RAY. A; RAY.B), an industry leader in music and video content distribution, business services, and advertising solutions, proudly announces its contribution in the grand opening of BMO's new branch at CF Toronto Eaton Centre. This state-of-the-art, full-service branch features Stingray Business's cutting-edge digital signage solutions, highlighting the integration of advanced technology in customer experiences.

The BMO branch in the CF Toronto Eaton Centre is strategically located on the corner of Yonge and  Dundas near Sankofa Square, one of Toronto's busiest intersections and a vibrant hub of innovation and activity. Its two-story wraparound windows presented a unique opportunity to elevate BMO’s brand presence, showcase an innovative approach to marketing, while maintaining a welcoming and comfortable customer experience within the branch. To maximize this unique opportunity, BMO partnered with Stingray Business to implement an innovative digital signage solution.

BRIDGEWATER, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) approval of prednisolone acetate ophthalmic suspension, 1% sterile which references Pred Forte^®. Pred Forte and its design are trademarks of Allergan, Inc., an AbbVie company. Launch of this product is planned for the third quarter of 2025.

MAINZ and TÜBINGEN, Germany, June 12, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”) and CureVac N.V. (Nasdaq: CVAC, “CureVac”) today announced that they have entered into a definitive Purchase Agreement pursuant to which BioNTech intends to acquire all of the shares of CureVac, a clinical-stage biotech company developing a novel class of transformative medicines in oncology and infectious diseases based on messenger ribonucleic acid (“mRNA”). The all-stock transaction will bring together two highly complementary companies based in Germany and will build on BioNTech’s proven track record and established position in the global mRNA industry.

CHANTILLY, Va., June 12, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) celebrated two station dedications on the new Foothill Gold Line light rail segment between Glendora and Pomona in Southern California’s San Gabriel Valley. The 9.1-mile segment achieved substantial completion in January, and the project has been turned over to the Los Angeles County Metropolitan Transportation Authority (Metro) for final testing, training, and preparation for passenger service, which is anticipated to begin later this year. Once operational, the new extension will be renamed, as it will be part of the 48.5-mile Metro A Line system - the longest light rail line in the country, that will carry passengers between Long Beach and Pomona.